Cure My Disease

Don't miss your cure!

 Log in / Sign up

Emergency rooms as prevention hubs: personalized advice may improve health behaviors

NCT ID NCT07714460

Prevention Sponsor: Centre Hospitalier le Mans Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 20, 2026 · Last updated Jul 23, 2026 · Updated 3 times

Summary

This trial tests whether giving patients personalized prevention tips in the emergency department helps them follow through on recommended health measures, like cancer screenings and vaccines. About 658 adults visiting two ERs in France receive either tailored advice based on their age, sex, and habits, or general information. Researchers check 6-8 weeks later whether patients have taken at least a quarter of the steps recommended for them.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
personalized preventive health information
What this could lead to
If effective, this approach could turn emergency department visits into opportunities to improve public health by increasing participation in screenings and vaccinations.
What could go wrong
This is an early exploratory trial, and the effect may be small or limited to certain groups. Adherence is measured only 6-8 weeks later, so long-term impact is unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 658 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients (≥ 18 years of age) * Patients seen in the emergency departments of Le Mans University Hospital and the PSSL * Patients who have given their free and informed oral consent Exclusion Criteria: * Patients who have previously participated in the study * Patients with limited understanding of the French language * Patients unable to give informed consent * Individuals not enrolled in or not eligible for a social security program * Individuals deprived of their liberty by judicial or administrative order * Individuals receiving involuntary psychiatric care * Individuals subject to a legal protective measure * Pregnant or breastfeeding patients.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Prevention are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Prevention

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Centre Hospitalier du Mans

    Le Mans, Sarthe, 72000, France

  • Pôle Santé Sarthe et Loir

    La Flèche, Sarthe, 72205, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.